Home > Insider Trading > Filing (0001144204-13-033382)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1115047	I Timothy Maudlin	4520 East West Hwy, 3Rd Floor Bethesda MD US 20814		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2013-05-15	32,870	$9.82	32,870	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Director Stock Option (Right to Buy)	Acquisiton	2013-05-15	32,870	$9.82	32,870	$5.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,870	2011-05-20	2022-05-22	No	4	P	Direct

Footnotes

Shares in the amount of 32,870 were purchased through the exercise, on a net basis, of 36,629 stock options. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 2 is a weighted average price. The conversion price of these shares were granted in multiple option awards at prices ranging from $3.56 to $7.71, inclusive.
The options became excerisable from dates ranging from 05/20/2011 to 02/25/2013, inclusive.
The options had expiration dates ranging from 05/22/2019 to 05/22/2022, inclusive.